JP2010215644A5 - - Google Patents

Download PDF

Info

Publication number
JP2010215644A5
JP2010215644A5 JP2010117814A JP2010117814A JP2010215644A5 JP 2010215644 A5 JP2010215644 A5 JP 2010215644A5 JP 2010117814 A JP2010117814 A JP 2010117814A JP 2010117814 A JP2010117814 A JP 2010117814A JP 2010215644 A5 JP2010215644 A5 JP 2010215644A5
Authority
JP
Japan
Prior art keywords
group
phenyl
trifluoromethyl
alkyl
pyrrolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010117814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010215644A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010117814A priority Critical patent/JP2010215644A/ja
Priority claimed from JP2010117814A external-priority patent/JP2010215644A/ja
Publication of JP2010215644A publication Critical patent/JP2010215644A/ja
Publication of JP2010215644A5 publication Critical patent/JP2010215644A5/ja
Withdrawn legal-status Critical Current

Links

JP2010117814A 2002-06-06 2010-05-21 抗アレルギー薬 Withdrawn JP2010215644A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010117814A JP2010215644A (ja) 2002-06-06 2010-05-21 抗アレルギー薬

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002165148 2002-06-06
JP2010117814A JP2010215644A (ja) 2002-06-06 2010-05-21 抗アレルギー薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004510784A Division JP4660674B2 (ja) 2002-06-06 2003-06-05 抗アレルギー薬

Publications (2)

Publication Number Publication Date
JP2010215644A JP2010215644A (ja) 2010-09-30
JP2010215644A5 true JP2010215644A5 (enExample) 2011-03-10

Family

ID=29727583

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004510784A Expired - Fee Related JP4660674B2 (ja) 2002-06-06 2003-06-05 抗アレルギー薬
JP2010117814A Withdrawn JP2010215644A (ja) 2002-06-06 2010-05-21 抗アレルギー薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004510784A Expired - Fee Related JP4660674B2 (ja) 2002-06-06 2003-06-05 抗アレルギー薬

Country Status (10)

Country Link
US (4) US20060122243A1 (enExample)
EP (1) EP1514544A4 (enExample)
JP (2) JP4660674B2 (enExample)
KR (1) KR101054562B1 (enExample)
CN (1) CN1658872B (enExample)
AU (1) AU2003242103A1 (enExample)
CA (1) CA2488367A1 (enExample)
EA (1) EA009701B1 (enExample)
TW (1) TW200402291A (enExample)
WO (1) WO2003103665A1 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002049632A1 (en) * 2000-12-18 2002-06-27 Institute Of Medicinal Molecular Design. Inc. Inhibitors against the production and release of inflammatory cytokines
US7626042B2 (en) 2002-06-06 2009-12-01 Institute Of Medicinal Molecular Design, Inc. O-substituted hydroxyaryl derivatives
AU2003242103A1 (en) 2002-06-06 2003-12-22 Institute Of Medicinal Molecular Design, Inc Antiallergic agents
EP1535609A4 (en) * 2002-06-10 2009-01-07 Inst Med Molecular Design Inc Nf-kb activation inhibitors
EA010835B1 (ru) * 2002-06-10 2008-12-30 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Лекарственное средство для лечения рака
EP1542699A4 (en) 2002-07-15 2009-03-25 Myriad Genetics Inc COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
US20070042997A1 (en) * 2003-07-16 2007-02-22 Akiko Itai Medicament for treatment of dermal pigmentation
WO2005028441A1 (ja) * 2003-09-17 2005-03-31 Sumitomo Chemical Company, Limited シンナモイル誘導体およびその用途
CA2538960C (en) 2003-09-17 2013-03-19 Sumitomo Chemical Company, Limited Cinnamoyl compound and use of the same
JPWO2006013873A1 (ja) * 2004-08-05 2008-05-01 株式会社医薬分子設計研究所 シクロオキシゲナーゼ阻害作用を有する医薬
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
WO2006077901A1 (ja) * 2005-01-20 2006-07-27 Shionogi & Co., Ltd. Ctgf発現阻害剤
CN101193862B (zh) * 2005-04-13 2013-08-21 阿斯特克斯治疗有限公司 羟基苯甲酰胺衍生物和其作为hsp90抑制剂的用途
US7754725B2 (en) * 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
US7671058B2 (en) 2006-06-21 2010-03-02 Institute Of Medicinal Molecular Design, Inc. N-(3,4-disubstituted phenyl) salicylamide derivatives
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
JP5721949B2 (ja) 2006-10-12 2015-05-20 アステックス、セラピューティックス、リミテッドＡｓｔｅｘ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ 複合薬剤
US8916552B2 (en) * 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
JP5410285B2 (ja) * 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
JP5518478B2 (ja) 2006-10-12 2014-06-11 アステックス、セラピューティックス、リミテッド 医薬化合物
US7737149B2 (en) 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CA2728063A1 (en) * 2008-06-19 2009-12-23 Astrazeneca Ab Pyrazole compounds 436
DE102011083271A1 (de) * 2011-09-23 2013-03-28 Beiersdorf Ag Aromatische Amidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Aromatischen Amidothiazolen
CN104602682B (zh) 2012-05-08 2018-12-14 埃罗米克斯公司 用于治疗水通道蛋白介导的疾病的化合物
US20140179712A1 (en) 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide
JP6083770B2 (ja) 2013-09-13 2017-02-22 昭子 板井 水溶液製剤及びその製造方法
EP3065729A4 (en) 2013-11-06 2017-05-31 Aeromics, Inc. Novel formulations
ES2661000T3 (es) 2014-09-12 2018-03-27 Antibiotx A/S Uso antibacteriano de salicilanilidas halogenadas
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
CA2986930C (en) 2015-06-24 2023-09-26 Duke University Chemical modulators of signaling pathways and therapeutic use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
UY39881A (es) * 2021-08-02 2023-06-15 Eurofarma Laboratorios S A “COMPUESTOS N-ACILHIDRAZÓNICOS INHIBIDORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, COMPOSICIONES, USOS, MÉTODOS DE TRATAMIENTO DE ESTOS Y KITS”
WO2023107880A1 (en) * 2021-12-06 2023-06-15 Albert Einstein College Of Medicine Mitofusin inhibitors and uses thereof
PY2404093A (es) * 2023-01-30 2024-10-03 Eurofarma Laboratorios S A Hidrazidas bloqueadoras de nav 1.7 y/o nav 1.8, sus procesos de obtención, composiciones, usos, métodos de tratamiento de los mismos y kits
WO2024159285A1 (pt) * 2023-01-30 2024-08-08 Eurofarma Laboratórios S.A. Compostos aril piridinas bloqueadores de nav 1.7 e/ou nav 1.8, seus processos de obtenção, composições, usos, métodos de tratamento destes e kits
PY2404641A (es) * 2023-01-30 2024-10-03 Eurofarma Laboratorios S A COMPUESTOS FENÓLICOS BLOQUEADORES DE Nav 1.7 Y/O Nav 1.8, SUS PROCESOS DE OBTENCIÓN, SUS COMPOSICIONES, SUS USOS, LOS MÉTODOS DE TRATAMIENTO DE LOS MISMOS Y SUS KITS
CN117105810B (zh) * 2023-10-23 2024-02-09 中国农业大学 一种具有广谱抗菌活性的化合物及其抗菌组合物
KR102964080B1 (ko) 2023-11-03 2026-05-13 재단법인 대구경북첨단의료산업진흥재단 아릴에텐 유도체를 유효성분으로 포함하는 아토피성 피부염 치료용 조성물

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2199A (en) * 1841-07-29 Improvement in the manufacture of buttons
US259877A (en) * 1882-06-20 Under-garment for infants
US165398A (en) * 1875-07-06 Improvement in processes for cleansing gas-retorts
US19958A (en) * 1858-04-13 Improvement in raking attachments to harvesters
US87650A (en) * 1869-03-09 Improvement in the manufacture of artificial fuel
US48891A (en) * 1865-07-25 Improved vessel for holding petroleum
US122244A (en) * 1871-12-26 Improvement in fire-extinguishers
US19412A (en) * 1858-02-23 Improvement in shovel-plows
US69267A (en) * 1867-09-24 Improved means for extinguishing fire in steamships
US141811A (en) * 1873-08-12 Improvement sn reefing fore and aft sails
US157844A (en) * 1874-12-15 Improvement in steam x c cylinder lubricators
DE1017606B (de) 1951-12-29 1957-10-17 Geigy Ag J R Verfahren zur Herstellung von baktericiden Salicylaniliden
JPS37225B1 (enExample) 1958-07-23 1962-01-23
BE615511A (enExample) * 1961-03-25
GB996074A (en) * 1962-02-27 1965-06-23 Herbert Christian Stecker Improvements in or relating to germicidal compositions
NL292958A (enExample) * 1962-05-29 1900-01-01
GB1079177A (en) 1963-06-11 1967-08-16 Stecker Internat S P A Improvements in pesticide composition for destroying internal worm parasites in animals
FR1481713A (fr) 1965-10-11 1967-05-19 Stecker Internat S P A Benzoazinediones et compositions germicides qui les contiennent
GB1099865A (en) 1965-10-11 1968-01-17 Stecker Internat S P A Benzoazinediones and germicidal compositions made therewith
DE2120862A1 (de) * 1971-04-28 1972-11-09 Farbenfabriken Bayer Ag, 5090 Leverkusen 3,5-Disubstituierte 2-Acyloxybenzoesäureanilide, Verfahren zu ihrer Herstellung und ihre insektizide und akarizide Verwendung
JPS52110835A (en) 1976-03-11 1977-09-17 Microbial Chem Res Found Remedy for immunological diseases containing benzanilide derivative as active ingredient
FR2434158A1 (fr) 1978-08-25 1980-03-21 Esteve Int Prod Nouveaux derives de 1,3-benzoxazine-2,4-dione, leur preparation et leur application en tant que medicaments
US4358443A (en) * 1980-04-14 1982-11-09 The Research Foundation Of State University Of New York Method and composition for controlling the growth of microorganisms
JPS57112360A (en) * 1980-08-08 1982-07-13 Risaachi Fuandeeshiyon Obu Sut Microbe growth controlling compound and method
CA1219587A (en) 1981-12-14 1987-03-24 Norman P. Jensen Hydroxybenzylaminobenzenes as anti-inflammatory agents
JPS59118750A (ja) * 1982-12-27 1984-07-09 Eisai Co Ltd カルボン酸アミド化合物およびその誘導体
US4742083A (en) * 1983-08-24 1988-05-03 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
JPS6299329A (ja) * 1983-08-24 1987-05-08 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 皮膚用抗炎症組成物
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
US4725590A (en) * 1983-08-24 1988-02-16 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
JPS6230780A (ja) * 1985-04-17 1987-02-09 Ss Pharmaceut Co Ltd １，７−ナフチリジン誘導体及びこれを含有する薬剤
US4939133A (en) 1985-10-01 1990-07-03 Warner-Lambert Company N-substituted-2-hydroxy-α-oxo-benzeneacetamides and pharmaceutical compositions having activity as modulators of the arachidonic acid cascade
JPH0755902B2 (ja) 1986-10-21 1995-06-14 株式会社ツムラ アルド−スリダクタ−ゼ阻害剤
JPS6487491A (en) 1987-09-30 1989-03-31 Hitachi Ltd Guide apparatus for passenger conveyor
US4786644A (en) 1987-11-27 1988-11-22 Hoechst-Roussel Pharmaceuticals Inc. 1-aryl-3-quinolinecarboxamide
US4952588A (en) * 1987-11-27 1990-08-28 Hoechst-Roussel Pharmaceuticals Inc. 1-aryl-3-quinoline-and 1-aryl-3-isoquinoline-carboxamides
US4966906A (en) * 1987-11-27 1990-10-30 Hoechst-Roussel Pharmaceuticals Inc. 1-aryl-3-isoquinolinecarboxamides
JP2988739B2 (ja) 1990-04-16 1999-12-13 協和醗酵工業株式会社 １，８−ナフチリジン−２−オン誘導体
JPH04217916A (ja) 1990-06-21 1992-08-07 Japan Tobacco Inc 抗炎症剤
AU641052B2 (en) 1990-11-02 1993-09-09 Aventisub Ii Inc. 3-amidoindolyl derivatives
US6159988A (en) * 1992-01-16 2000-12-12 Hoeschst Aktiengesellschaft Arylcycloalkyl derivatives, their production and their use
CZ285937B6 (cs) 1992-01-16 1999-12-15 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, způsob přípravy těchto derivátů a jejich použití
US5679696A (en) * 1992-07-28 1997-10-21 Rhone-Poulenc Rorer Limited Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic-or heteroatom-containing linking group
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
JPH08175990A (ja) 1994-12-19 1996-07-09 Mitsubishi Chem Corp Ｐｉ３キナーゼ阻害剤とその製造法
US5935966A (en) * 1995-09-01 1999-08-10 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
US5852028A (en) * 1995-12-18 1998-12-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
US5811428A (en) * 1995-12-18 1998-09-22 Signal Pharmaceuticals, Inc. Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
JPH09169747A (ja) 1995-12-18 1997-06-30 Kyorin Pharmaceut Co Ltd 新規置換フェニルチアゾリジン−２，４−ジオン誘導体及びその製造法
JPH09203951A (ja) 1996-01-26 1997-08-05 Minolta Co Ltd カートリッジホルダーの防水機構
JPH09227561A (ja) 1996-02-21 1997-09-02 Tanabe Seiyaku Co Ltd キサンチン誘導体
JPH1045738A (ja) 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンｃおよびｄとその製造法ならびに抗リウマチ剤
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
JP2002512685A (ja) * 1997-01-15 2002-04-23 テリック・インコーポレイテッド インスリン受容体活性のモジュレーター
JPH1121243A (ja) 1997-05-06 1999-01-26 Tanabe Seiyaku Co Ltd 医薬組成物
JPH1121225A (ja) 1997-06-27 1999-01-26 Tanabe Seiyaku Co Ltd 美白用成分およびこれを含有する美白用皮膚外用剤
US6117859A (en) * 1997-11-04 2000-09-12 The Research Foundation Of State University Of New York Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides
US6022884A (en) * 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use
JPH11180873A (ja) * 1997-12-22 1999-07-06 Kaken Shoyaku Kk ＮＦ−κＢ活性阻害剤
WO1999040907A1 (en) * 1998-02-13 1999-08-19 Medinox, Inc. Methods for the controlled delivery of carbon disulfide for the treatment of inflammatory conditions
WO1999046244A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
US20020002199A1 (en) * 1998-03-12 2002-01-03 Lone Jeppesen Modulators of protein tyrosine phosphatases (ptpases)
US6225329B1 (en) * 1998-03-12 2001-05-01 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPases)
ATE308546T1 (de) 1998-03-12 2005-11-15 Novo Nordisk As Modulatoren der protein tyrosin phosphatase (ptpases)
WO1999046236A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
US20020019412A1 (en) 1998-03-12 2002-02-14 Henrik Sune Andersen Modulators of protein tyrosine phosphatases (ptpases)
WO1999046267A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
US6262044B1 (en) * 1998-03-12 2001-07-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPASES)
AU2854399A (en) * 1998-03-20 1999-10-18 Daiichi Suntory Pharma Co., Ltd NF-kappa inhibitors containing as the active ingredient phenylmethyl benzoquinone
EP1076641A1 (en) * 1998-04-29 2001-02-21 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
HUP0102782A3 (en) * 1998-06-19 2002-12-28 Smithkline Beecham Corp Salycilanilide as inhibitors of transcription factor nf-kb
ES2219033T3 (es) 1998-07-22 2004-11-16 Daiichi Suntory Pharma Co., Ltd. Inhibidores de nf-kappa b que contienen derivados de indano como ingrediente activo.
WO2000015603A1 (en) 1998-09-11 2000-03-23 Ajinomoto Co., Inc. Benzene derivatives and medicinal use thereof
JP2000169479A (ja) 1998-12-09 2000-06-20 Kyowa Hakko Kogyo Co Ltd ＮＦ−κＢ活性化阻害剤
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6653309B1 (en) * 1999-04-26 2003-11-25 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme technical field of the invention
EP1205478A4 (en) 1999-08-06 2004-06-30 Takeda Chemical Industries Ltd P38MAP KINASE INHIBITORS
WO2001012588A1 (en) * 1999-08-11 2001-02-22 Mercian Corporation Salicylamide derivatives
DE60020786T2 (de) 1999-09-30 2006-03-23 Pfizer Products Inc., Groton 6-Azauracilderivate als Liganden der Thyroidrezeptoren
US6787652B1 (en) * 1999-09-30 2004-09-07 Pfizer, Inc. 6-Azauracil derivatives as thyroid receptor ligands
US6706766B2 (en) * 1999-12-13 2004-03-16 President And Fellows Of Harvard College Small molecules used to increase cell death
US6414013B1 (en) 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
EP1182251A1 (en) * 2000-08-11 2002-02-27 Yissum Research Development Company of the Hebrew University of Jerusalem Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkB
JP4086658B2 (ja) * 2000-10-02 2008-05-14 ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク 抗菌薬および抗炎症剤としてのナフチルサリチルアニリド
WO2002049632A1 (en) 2000-12-18 2002-06-27 Institute Of Medicinal Molecular Design. Inc. Inhibitors against the production and release of inflammatory cytokines
CN1289072C (zh) 2000-12-22 2006-12-13 石原产业株式会社 苯胺衍生物或其盐以及含有它们的细胞因子产生抑制剂
JP4083422B2 (ja) * 2000-12-22 2008-04-30 石原産業株式会社 アニリン誘導体またはその塩ならびにそれらを含有するサイトカイン産生抑制剤
JPWO2002076918A1 (ja) * 2001-03-27 2004-07-15 第一サントリーファーマ株式会社 置換安息香酸誘導体を有効成分とするＮＦ−κＢ阻害剤
US20040025987A1 (en) * 2002-05-31 2004-02-12 Bhagwat Anand W. High carbon steel wire with bainitic structure for spring and other cold-formed applications
EA009523B1 (ru) 2002-06-05 2008-02-28 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Ингибиторы в отношении активации ар-1 и nfat
WO2003103658A1 (ja) 2002-06-05 2003-12-18 株式会社医薬分子設計研究所 免疫関連プロテインキナーゼ阻害剤
AU2003242103A1 (en) 2002-06-06 2003-12-22 Institute Of Medicinal Molecular Design, Inc Antiallergic agents
EA010835B1 (ru) 2002-06-10 2008-12-30 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. Лекарственное средство для лечения рака
EP1535609A4 (en) 2002-06-10 2009-01-07 Inst Med Molecular Design Inc Nf-kb activation inhibitors
US20060035944A1 (en) 2002-06-11 2006-02-16 Susumu Muto Remedies for neurodegenerative diseases
WO2004006906A2 (en) 2002-07-15 2004-01-22 Combinatorx, Incorporated Methods for the treatment of neoplasms
US20070042997A1 (en) 2003-07-16 2007-02-22 Akiko Itai Medicament for treatment of dermal pigmentation
US7059195B1 (en) * 2004-12-02 2006-06-13 Honeywell International Inc. Disposable and trimmable wireless pressure sensor for medical applications
JP4217981B2 (ja) 2005-02-08 2009-02-04 Ｓｍｃ株式会社 直動・回転複合アクチュエータ
JP4217916B2 (ja) 2006-02-15 2009-02-04 三菱ふそうトラック・バス株式会社 ハイブリッド電気自動車の制御装置

Similar Documents

Publication Publication Date Title
RU2454415C9 (ru) Производное индола
JP5517935B2 (ja) 細胞壊死阻害剤としてのインドール及びインダゾール化合物
RU2006104697A (ru) Лекарственное средство для лечения пигментации кожи
RU2458920C2 (ru) Новые соединения
RU2012116207A (ru) Производные индола в качестве модуляторов crac
NZ591427A (en) P38 map kinase inhibitors
JP2010506825A5 (enExample)
RU2014142598A (ru) Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в
JP2016512825A5 (enExample)
RU2011134631A (ru) Вызывающие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний
KR970001322A (ko) 당뇨병 저해제로서의 치환 n-[인돌-2-카보닐]-글리신아미드 및 유도체
CA2542609A1 (en) Novel indazole derivatives
JP2012510989A5 (enExample)
RU2015104962A (ru) Ди- и тригетероарильные производные в качестве ингибиторов агрегации белков
HRP20140588T1 (hr) Spojevi kondenziranog prstena i njihova uporaba
JP2013517273A5 (enExample)
NZ592297A (en) 2-Aryl-5-heteroaryl pyridine and pyrimidine derivatives as pharmaceutical active agents
HRP20141190T1 (hr) Disupstituirani derivati piridina kao antikancerogena sredstva
JP2013531055A5 (enExample)
JP2014523400A5 (enExample)
NZ612544A (en) Heterocyclic compounds suitable for the treatment of dyslipidemia
HRP20100284T1 (hr) Derivati piperazinila korisni u liječenju bolesti posredovanih receptorom gpr38
JP2013539786A5 (enExample)
JP2020500192A5 (enExample)
JP2016510810A5 (enExample)